𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of furosemide after three different single oral doses

✍ Scribed by Elaine S. Waller; Joseph W. Massarella; Motria Sharanevych Tomkiw; Robert V. Smith; James T. Doluisio


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
396 KB
Volume
6
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis


Furosemide solution was orally administered to 21 healthy adult males to determine dose proportionality over the dose range used and the reproducibility of disposition following a repeated dose. Furosemide solution was given in doses of 20,40, and 80mg, with the 40 mg dose repeated once. Blood was collected for 12 hours post-dose and urine for 24 hours. The maximum plasma concentrations resulting from 20,40, and 80mg doses were significantly different (p < 0.05). Dose normalized maximum concentrations for the 20 and 80mg doses were significantly different (p<0.05). Mean time to Cp,,, was 50 minutes, with no differences observed among doses. Plasma AUCs were significantly different (p<0.05) for 20. 40, and 80mg. Dose normalized AUCs were not significantly different. Mean amounts of furosemide in urine (Xu) were 9.62, 16.7, and 32.0mg for the 20,40, and 80 mg doses, respectively. These amounts were significantly different ( p <O.OS); dose normalized amounts were not significantly different. Renal clearances of furosemide following the three doses were not significantly different. Regressions of Cp,,,, AUC and Xu on dose were significant. There were no significant differences in Cp,,,, rmax, AUC or Xu for 40 mg given on two separate days. Renal clearance of furosemide was statistically different for 40mg given on two separate days, but the difference was not clinically significant. The pharmacokinetics of furosemide are linear over the dosage range studied. Furosemide 40 mg given on two separate days results in similar disposition parameters.


πŸ“œ SIMILAR VOLUMES


Clinical pharmacokinetics of procaterol:
✍ Dr Michael A. Eldon; Debbie S. Blake; Michael J. Coon; Gerald D. Nordblom; Allen πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 2 views

Procaterol is a potent, orally active &-agonist bronchodilator useful in the treatment of reversible bronchospastic disease. It is effective when administered as single or multiple (Q8H) 50 and 75pg doses. As part of the clinical development of procaterol, the pharmacokinetics and dose proportionali

Pharmacokinetics of azithromycin after s
✍ D. Davila; Lidija Kolačny-babiΔ‡; F. PlavΕ‘iΔ‡ πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 421 KB πŸ‘ 2 views

## Abstract Azithromycin, a macrolide antibiotic with an enhanced antimicrobial spectrum, was found to have a longer half‐life than erythromycin, with marked tissue penetration. The pharmacokinetics of azithromycin after oral administration were compared with those of erythromycin in rats (200 mg k

Pharmacokinetics of deramciclane in dogs
✍ Harri Kanerva; Hannele Huuskonen; Anneli Alhonen-Raatesalmi; Timo Nevalainen; Ar πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 204 KB πŸ‘ 2 views

The pharmacokinetics of a new serotonin 5-HT 2 antagonist, deramciclane, was studied. Single oral doses of 1, 3, 6 and 10 mg kg -1 and intravenous doses of 1, 3 and 6 mg kg -1 were administered in beagle dogs. Moreover, the steady state pharmacokinetics of 1, 3 and 6 mg kg -1 doses were studied. Der

Pharmacokinetics of fluvoxamine maleate
✍ M. H. De Vries; J. Van Harten; P. Van Bemmel; M. Raghoebar πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 286 KB πŸ‘ 1 views

The pharmacokinetics of fluvoxamine after single oral administration of 25, 50, and 100mg fluvoxamine maleate was studied in a three-way cross-over study in 12 healthy male subjects. Fluvoxamine was administered orally in a solution. For doseproportionality, AUC, and C,-dose relationships were evalu

Pharmacokinetics and safety of single or
✍ Dr. Irwin S. Morse πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 444 KB πŸ‘ 2 views

The pharmacokinetics of 100 mg, 200 mg, 400 mg, 600 mg, and 800 mg of lomefloxacin, a quinolone antimicrobial, were examined in a single sequential rising dose, placebocontrolled, crossover study. Each of 30 healthy male subjects (6 per group) received placebo and one dose of lomefloxacin, separated

Pharmacokinetics of the novel anticonvul
✍ Lisbeth E. GΓ³mez M.; Pedro A. Lehmann F. πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 385 KB πŸ‘ 2 views

HEPP (D, L-3-hydroxy-3-ethyl-3-phenylpropanamide) is a novel compound with a wide spectrum of anticonvulsant activity and relatively low toxicity. The aim of this investigation was to study the pharmacokinetics of HEPP in mongrel dogs and to assess its linearity after intravenous administration of 8